China Aoxing Completes Trial of Pain Drug
January 25, 2010 at 04:57 AM EST
China Aoxing Pharmaceutical Company has completed its Phase III trial of Tilidine tablets, an synthetic oral narcotic drug that treats acute and chronic moderate to severe pain, including post-operative and cancer pain. The drug, which is not currently available in China, is a Class III New Medicine that will enjoy at least four years of market exclusivity protection, post-approval. More details... Stock Symbol: (OTCBB: CAXG)